These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 8729590

  • 1. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP, Serruys PW.
    Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease.
    Lemos PA, de Feyter PJ, Serruys PW, Saia F, Arampatzis CA, Disco C, Mercado N, Mainar V, Morís C, van den Bos AA, Berghoefer G.
    Int J Cardiol; 2005 Feb 28; 98(3):479-86. PubMed ID: 15708183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB, Karsch KR.
    Blood Coagul Fibrinolysis; 1993 Dec 28; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [Abstract] [Full Text] [Related]

  • 11. Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
    Lemos PA, Serruys PW, de Feyter P, Mercado NF, Goedhart D, Saia F, Arampatzis CA, Soares PR, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand V.
    Am J Cardiol; 2005 Feb 15; 95(4):445-51. PubMed ID: 15695126
    [Abstract] [Full Text] [Related]

  • 12. Fluvastatin: a review of its use in lipid disorders.
    Langtry HD, Markham A.
    Drugs; 1999 Apr 15; 57(4):583-606. PubMed ID: 10235694
    [Abstract] [Full Text] [Related]

  • 13. [Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies].
    Yoshinuma M.
    J Cardiol; 1999 Feb 15; 33(2):81-8. PubMed ID: 10087476
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Despite coronary intervention, the risk remains high: PCI patients need additional protection].
    MMW Fortschr Med; 2004 Jun 10; 146(24):3. PubMed ID: 15366508
    [No Abstract] [Full Text] [Related]

  • 18. Relevance of hemostasis on restenosis in clinically stable patients undergoing elective PTCA.
    Schoebel FC, Peters AJ, Kreis I, Gradaus F, Heins M, Jax TW.
    Thromb Res; 2008 Jun 10; 122(2):229-36. PubMed ID: 18054069
    [Abstract] [Full Text] [Related]

  • 19. [Restenosis and arterial remodelling after coronary angioplasty].
    Jørgensen B, Forfang K.
    Tidsskr Nor Laegeforen; 1996 Aug 30; 116(20):2460-3. PubMed ID: 8928109
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.